Quarterly report pursuant to Section 13 or 15(d)

Investment in account receivable (Details Narrative)

v3.23.1
Investment in account receivable (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Feb. 16, 2022
Feb. 15, 2022
Apr. 10, 2015
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
Jan. 10, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Warrants price per share       $ 2.11   $ 2.11    
Warrants redemption price       $ 0.10        
Impairment of investments             $ (139,148)  
Gain (loss) on investment receivable   $ 41,930   $ (42,680) $ 41,930 $ 22,718  
Annual installment payments               $ 117,000
Due in 2023               117,000
Due in 2024               117,000
Due in 2025               $ 117,000
Amortization of debt discount       $ 6,456 13,470      
Series D Warrants [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Warrants price per share       $ 1.60        
Exchange Agreement [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Account receivable with annual installment payments     $ 117,000          
Annual installment receivable, term     11 years          
Shares issued, value     $ 1,287,000          
Shares issued, shares     757,059          
Investment in account receivable discount percent             17.87%  
Annual payments $ 100,000              
Annual payment term 4 years              
Debt instrument, periodic payment $ 100              
Loss on investment       $ 0 $ 41,930      
Exchange Agreement [Member] | Series D Warrants [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Warrants issued     757,059          
Warrants price per share     $ 1.60          
Warrants redemption price     $ 0.10